1.6500
22-نوفمبر-24 15:44:58
15 متأخرة بدقائق
الأسهم
+0.0500
+3.12%
نطاق اليوم
1.5800 - 1.6800
ISIN
N/A
المصدر
NASDAQ
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
02 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
25 مارس 2024 06:06:46 بحسب Nasdaq GlobeNewswire